TERMS AGREEMENT
Exhibit 1.1
January 23, 2007
Apache Corporation
One Post Oak Central
0000 Xxxx Xxx Xxxxxxxxx
Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Attention: Vice President and Treasurer
One Post Oak Central
0000 Xxxx Xxx Xxxxxxxxx
Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Attention: Vice President and Treasurer
Ladies and Gentlemen:
The undersigned underwriters (the “Underwriters”) understand that Apache Corporation (the
“Company”) proposes to issue and sell $500,000,000 aggregate principal amount of its 5.625% Notes
due 2017 (the “2017 Notes”) and $1,000,000,000 aggregate principal amount of its 6.000% Notes due
2037 (the “2037 Notes” and, together with the 2017 Notes, the “Offered Securities”). Subject to
the terms and conditions set forth herein or incorporated by reference herein, the Underwriters
offer to purchase, severally and not jointly, the principal amount of Offered Securities set forth
below opposite their respective names at 99.254% of the principal amount of the 2017 Notes and at
98.426% of the principal amount of the 2037 Notes, respectively, in each case together with accrued
interest thereon from January 26, 2007 to the Closing Time:
Principal | Principal | |||||||
Amount of | Amount of | |||||||
Underwriter | 2017 Notes | 2037 Notes | ||||||
Banc of America Securities LLC |
$ | 160,000,000 | $ | 320,000,000 | ||||
X.X. Xxxxxx Securities Inc. |
160,000,000 | 320,000,000 | ||||||
BMO Capital Markets Corp. |
30,000,000 | 60,000,000 | ||||||
BNP Paribas Securities Corp. |
30,000,000 | 60,000,000 | ||||||
Deutsche Bank Securities Inc. |
30,000,000 | 60,000,000 | ||||||
Greenwich Capital Markets, Inc. |
30,000,000 | 60,000,000 | ||||||
RBC Capital Markets Corporation |
30,000,000 | 60,000,000 | ||||||
Wachovia Capital Markets, LLC |
30,000,000 | 60,000,000 | ||||||
Total |
$ | 500,000,000 | $ | 1,000,000,000 | ||||
The Offered Securities shall have the following terms:
The 2017 Notes | ||
Principal amount:
|
$500,000,000 | |
Form:
|
Registered book-entry form | |
Minimum denomination:
|
$2,000 and integral multiples of $1,000 in excess thereof | |
Date of maturity:
|
January 15, 2017 | |
Interest rate:
|
5.625% per annum | |
Date from which interest accrues:
|
January 26, 2007 | |
Interest payment dates:
|
January 15 and July 15 of each year (commencing July 15, 2007) | |
Initial price to public:
|
$499,520,000 (99.904%) | |
Closing Time:
|
January 26, 2007 | |
Place of delivery and payment:
|
New York, New York | |
Company account for wire transfer of
payment:
|
Bank: Deutsche Bank Trust Company Americas City/State: New York, New York ABA Number: 000000000 SWIFT: XXXXXX00 Account Number: 00000000 Account Name: Apache Corporation |
|
Redemption provisions, if any:
|
As described in the Prospectus Supplement, dated the date hereof, relating to the Offered Securities | |
Lock-up pursuant to Section 3(i) of the
Basic Terms (as defined herein):
|
Yes | |
Letter from Xxxxx Xxxxx Company, L.P.
pursuant to Section 4(g) of the Basic
Terms:
|
Yes | |
Securities exchanges, if any, on which
application will be made to list the
2017 Notes:
|
None | |
Delayed Delivery Contracts:
|
Not Applicable | |
Applicable Time:
|
3:50 p.m. Eastern Standard Time, January 23, 2007 | |
Final Term Sheet:
|
As set forth in Schedule 1 | |
Other terms, if any:
|
None |
2
The Offered Securities shall have the following terms:
The 2037 Notes | ||
Principal amount:
|
$1,000,000,000 | |
Form:
|
Registered book-entry form | |
Minimum denomination:
|
$2,000 and integral multiples of $1,000 in excess thereof | |
Date of maturity:
|
January 15, 2037 | |
Interest rate:
|
6.000% per annum | |
Date from which interest accrues:
|
January 26, 2007 | |
Interest payment dates, if any:
|
January 15 and July 15 of each year (commencing July 15, 2007) | |
Initial price to public:
|
$993,010,000 (99.301%) | |
Closing Time:
|
January 26, 2007 | |
Place of delivery and payment:
|
New York, New York | |
Company account for wire transfer of
payment:
|
Bank: Deutsche Bank Trust Company Americas City/State: New York, New York ABA Number: 000000000 SWIFT: XXXXXX00 Account Number: 00000000 Account Name: Apache Corporation |
|
Redemption provisions, if any:
|
As described in the Prospectus Supplement, dated the date hereof, relating to the Offered Securities | |
Lock-up pursuant to Section 3(i) of the
Basic Terms (as defined herein):
|
Yes | |
Letter from Xxxxx Xxxxx Company, L.P.
pursuant to Section 4(g) of the Basic
Terms:
|
Yes | |
Securities exchanges, if any, on which
application will be made to list the
2037 Notes:
|
None | |
Delayed Delivery Contracts:
|
Not Applicable | |
Applicable Time:
|
3:50 p.m. Eastern Standard Time, January 23, 2007 | |
Final Term Sheet:
|
As set forth in Schedule 1 | |
Other terms, if any:
|
None |
3
Each of the Underwriters represents and agrees that:
(a) In relation to each Member State of the European Economic Area which has implemented the
Prospectus Directive (each, a “Relevant Member State”), with effect from and including the date on
which the Prospectus Directive is implemented in that Relevant Member State (the “Relevant
Implementation Date”) it has not made and will not make an offer of notes to the public in that
Relevant Member State prior to the publication of a prospectus in relation to the notes which has
been approved by the competent authority in that Relevant Member State or, where appropriate,
approved in another Relevant Member State and notified to the competent authority in that Relevant
Member State, all in accordance with the Prospectus Directive, except that it may, with effect from
and including the Relevant Implementation Date, make an offer of notes to the public in that
Relevant Member State at any time:
(i) to legal entities which are authorized or regulated to operate in the financial
markets or, if not so authorized or regulated, whose corporate purpose is solely to
invest in securities;
(ii) to any legal entity which has two or more of (1) an average of at least 250
employees during the last financial year; (2) a total balance sheet of more than EUR
43,000,000 and (3) an annual net turnover of more than EUR 50,000,000, as shown in
its last annual or consolidated accounts; or
(iii) in any other circumstances which do not require the publication by the
Company of a prospectus pursuant to Article 3 of the Prospectus
Directive.1
(b) | (i) it has only communicated or caused to be communicated and will only communicate or cause to be communicated an invitation or inducement to engage in investment activity (within the meaning of Section 21 of the Financial Services and Markets Xxx 0000 (“FSMA”)) received by it in connection with the issue or sale of the Offered Securities in circumstances in which Section 21(1) of the FSMA does not apply to the Company; and |
(ii) it has complied and will comply with all applicable provisions of the FSMA with
respect to anything done by it in relation to the Offered Securities in, from or
otherwise involving the United Kingdom.
1 For the purpose of this provision, the
expression an “offer of notes to the public” in relation to any
Offered Securities in any Relevant Member State means the communication in any
form and by any means of sufficient information on the terms of the offer and
the Offered Securities to be offered so as to enable an investor to decide to
purchase or subscribe the Offered Securities, as the same may be varied in that
Member State by any measure implementing the Prospectus Directive in that
Member State, and the expression Prospectus Directive means Directive
2003/71/EC and includes any relevant implementing measure in each Relevant
Member State.
4
All the provisions contained in “Apache Corporation-Debt Securities—Underwriting Agreement
Basic Terms” (the “Basic Terms”), to be filed as an exhibit to the Registration Statement relating
to the Offered Securities and attached hereto as Annex A, are herein incorporated by reference in
their entirety and shall be deemed to be a part of this Terms Agreement to the same extent as if
such provisions had been set forth in full herein. Terms defined in such document are used herein
as therein defined.
5
Any notice by the Company to the Underwriters pursuant to this Terms Agreement shall be
sufficient if given in accordance with Section 11 of the Basic Terms addressed to:
Banc of America Securities LLC | ||
00 Xxxx 00xx Xxxxxx | ||
Xxx Xxxx, Xxx Xxxx 00000 | ||
Attn: High Grade Debt | ||
Capital Markets | ||
Transaction Management | ||
Telephone: (000) 000-0000 | ||
Facsimile: (000) 000-0000 | ||
and | ||
X.X. Xxxxxx Securities Inc. | ||
000 Xxxx Xxxxxx | ||
Xxx Xxxx, Xxx Xxxx 00000 | ||
Attn: High Grade Syndicate Desk, 8th Fl. | ||
Facsimile: (000) 000-0000 |
which, shall, for all purposes of this Agreement, be the “Representatives”.
Very truly yours, | ||||||
BANC OF AMERICA SECURITIES LLC | ||||||
By: | /s/ Xxxx Xxxxx | |||||
Name: Xxxx Xxxxx | ||||||
Title: Principal | ||||||
X.X. XXXXXX SECURITIES INC. | ||||||
By: | /s/ Xxxxxx Xxxxxxxxx | |||||
Name: Xxxxxx Xxxxxxxxx | ||||||
Title: Vice President | ||||||
Acting for themselves and as Representatives of the Underwriters listed in Annex B |
Accepted: | ||||
APACHE CORPORATION | ||||
By:
|
/s/ Xxxxxxx X. Xxxxxxx | |||
Name: Xxxxxxx X. Xxxxxxx | ||||
Title: Vice President and Treasurer |
6
ANNEX A
[Apache Corporation – Debt Securities – Basic Terms]
Apache Corporation
Debt Securities
UNDERWRITING AGREEMENT BASIC TERMS
Apache Corporation
Debt Securities
UNDERWRITING AGREEMENT BASIC TERMS
Apache Corporation, a Delaware corporation (the “Company”), may issue and sell from time to
time its debt securities (the “Debt Securities”). The Debt Securities are issuable under an
indenture, dated as of February 15, 1996, as supplemented and amended pursuant to a First
Supplemental Indenture, dated as of November 5, 1996 (as so supplemented, the “Indenture”), between
the Company and The Bank of New York Trust Company, N.A. (as successor to XX Xxxxxx Xxxxx Bank,
N.A., formerly known as Chemical Bank), as trustee (the “Trustee”). Each issue of Debt Securities
may vary as to series, aggregate principal amount, maturity, interest rate or rates and timing of
payments thereof, redemption provisions, if any, and any other variable terms as set forth in the
Terms Agreement (as defined below) relating thereto which the Indenture contemplates may be set
forth in the Debt Securities as issued from time to time.
Whenever the Company determines to make an offering of Debt Securities, the Company will enter
into an agreement (the “Terms Agreement”) providing for the sale of such securities (the “Offered
Securities”) to, and the purchase and offering thereof by, one or more underwriters specified in
the Terms Agreement (the “Underwriters”, which term shall include any Underwriters substituted
pursuant to Section 10 hereof). The Terms Agreement relating to the Offered Securities shall
specify the names of the Underwriters participating in such offering, the amount of Offered
Securities which each such Underwriter severally agrees to purchase, the price at which the Offered
Securities are to be purchased by the Underwriters from the Company, the initial public offering
price, the time and place of delivery and payment, such other information as is indicated in
Exhibit A hereto and such other terms as are agreed by the Company and the Underwriters. In
addition, each Terms Agreement shall specify whether the Company has agreed to grant to the
Underwriters an option to purchase additional Offered Securities to cover over-allotments, if any,
and the amount of Offered Securities subject to such option (the “Option Securities”). As used
herein, the term “Offered Securities” shall include the Option Securities, if any, and
“Representatives” shall mean the Underwriter or Underwriters so specified in the Terms Agreement
or, if no Underwriter is so specified, shall mean each Underwriter. The Terms Agreement may be in
the form of an exchange of any standard form of written telecommunication between the Underwriters
and the Company. The offering of the Offered Securities will be governed by the Terms Agreement,
as supplemented hereby (collectively, this “Agreement”), and this Agreement shall inure to the
benefit of and be binding upon each Underwriter participating in the offering of the Offered
Securities.
The Company has prepared and filed with the Securities and Exchange Commission (the
“Commission”) a registration statement on Form S-3 (No. 333-105536) for the registration of Debt
Securities and other securities, including the Offered Securities, under the Securities Act of
1933, as amended (the “1933 Act”), and the offering thereof from time to time in accordance with
Rule 415 of the rules and regulations of the Commission under the 1933 Act (the “1933 Act
Regulations”), and has prepared and filed such amendments thereto as may have been required to the
date hereof. Such registration statement, as amended, has been declared effective by the
Commission, and the Indenture has been qualified under the Trust Indenture Act of 1939 (the
A-1
“1939 Act”). As provided in Section 3(a), a prospectus supplement reflecting the terms of the
Offered Securities, the terms of the offering thereof and the other matters set forth therein has
been prepared and will be filed pursuant to Rule 424 of the 1933 Act Regulations. Such prospectus
supplement, in the form first filed after the date of the Terms Agreement pursuant to such Rule
424, is herein referred to as the “Prospectus Supplement”. Such registration statement, as amended
at the date of the Terms Agreement, including the exhibits thereto, the documents incorporated by
reference therein and any information deemed to be a part thereof or included therein by the 1933
Act Regulations, is herein called the “Registration Statement”. Any registration statement filed
pursuant to Rule 462(b) of the 1933 Act Regulations is herein referred to as the “Rule 462(b)
Registration Statement,” and after such filing the term “Registration Statement” shall include the
Rule 462(b) Registration Statement. The basic prospectus included in the Registration Statement
relating to all offerings of Debt Securities under the Registration Statement (the “Base
Prospectus”), as supplemented by the Prospectus Supplement, is herein called the “Prospectus”,
except that, if the Base Prospectus is amended or supplemented on or prior to the date of any
applicable Terms Agreement, the term “Base Prospectus” shall refer to the Base Prospectus as so
amended or supplemented and the term “Prospectus” shall mean such Base Prospectus as supplemented
by the Prospectus Supplement from and after the time it is first provided to the Underwriters for
such use, in either case including the documents filed by the Company with the Commission pursuant
to the Securities Exchange Act of 1934, as amended (the “1934 Act”), that are incorporated by
reference therein. Any preliminary prospectus supplement to the Base Prospectus that describes the
Offered Securities and the offering thereof and is used prior to filing of the Prospectus pursuant
to Rule 424 of the 1933 Act Regulations is called, together with the Base Prospectus, a
“Preliminary Prospectus”. The term “Disclosure Package” shall mean (i) the Base Prospectus,
including any preliminary prospectus supplement, as amended or supplemented, (ii) the issuer free
writing prospectuses as defined in Rule 433 of the 1933 Act Regulations (each, an “Issuer Free
Writing Prospectus”), if any, identified in Schedule 1 to the applicable Terms Agreement, (iii) any
other free writing prospectus that the parties hereto shall hereafter expressly agree in writing to
treat as part of the Disclosure Package and (iv) the Final Term Sheet (as defined herein), which
also shall be identified in Schedule 1 to the applicable Terms Agreement.
SECTION 1. Representations and Warranties. The Company represents and warrants
to each Underwriter named in the Terms Agreement as of the date thereof, as of the
Applicable Time identified in such Terms Agreement and as of the Closing Time referred to in
Section 2(c) hereof, and as of each Date of Delivery (if any) referred to in Section 2(b)
hereof (in each case, a “Representation Date”), as follows:
(a) The Company has been duly incorporated and is validly existing as a corporation
in good standing under the laws of the State of Delaware with corporate power and
authority to own, lease and operate its properties and to conduct its business as
described in the Disclosure Package and the Prospectus and to enter into and perform
its obligations under this Agreement; and the Company is duly qualified as a foreign
corporation to transact business and is in good standing in the State of Texas and
in each other jurisdiction in which such qualification is required, whether by
reason of the ownership or leasing of property or the conduct of business, except
where the failure to so qualify and be in good standing would not have a material
adverse effect on the condition,
A-2
financial or otherwise, or the results of operations, business affairs or business
prospects of the Company and its subsidiaries considered as one enterprise.
(b) Each “significant subsidiary” of the Company as defined in Rule 405 of
Regulation C of the 1933 Act Regulations (collectively, the “Significant
Subsidiaries”) has been duly incorporated and is validly existing as a corporation
in good standing under the laws of the jurisdiction of its incorporation, has
corporate power and authority to own, lease and operate its properties and conduct
its business as described in the Disclosure Package and the Prospectus and is duly
qualified as a foreign corporation to transact business and is in good standing in
each jurisdiction in which such qualification is required, whether by reason of the
ownership or leasing of property or the conduct of business, except where the
failure to so qualify and be in good standing would not have a material adverse
effect on the condition, financial or otherwise, or the results of operations,
business affairs or business prospects of the Company and its subsidiaries
considered as one enterprise; and, except as described in the Disclosure Package and
the Prospectus, all of the issued and outstanding capital stock of each Significant
Subsidiary has been duly authorized and validly issued, is fully paid and
non-assessable and, except for directors’ qualifying shares (if applicable), is
owned by the Company, directly or through subsidiaries, free and clear of any
security interest, mortgage, pledge, lien, encumbrance, claim or equity.
(c) At the time the Registration Statement and the Rule 462(b) Registration
Statement, if any, became effective, at each deemed effective date with respect to
the Underwriters pursuant to Rule 430B(f)(2) of the 1933 Act Regulations and as of
each Representation Date, the Registration Statement and the Rule 462(b)
Registration Statement, if any, complied and will comply in all material respects
with the requirements of the 1933 Act and the 1933 Act Regulations and the 1939 Act
and the rules and regulations of the Commission promulgated thereunder; the
Registration Statement and the Rule 462(b) Registration Statement, if any, each at
the time it became effective, did not, and at each time thereafter at which any
amendment to the Registration Statement becomes effective or any Annual Report on
Form 10-K is filed by the Company with the Commission, at each deemed effective date
with respect to the Underwriters pursuant to Rule 430B(f)(2) of the 1933 Act
Regulations and as of each Representation Date, will not, contain an untrue
statement of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading; the Prospectus,
as of each Representation Date, does not and will not include an untrue statement of
a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made,
not misleading; and the Disclosure Package, as of the Applicable Time, did not
contain any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading, provided, however, that
the representations and warranties in this subsection shall not apply to statements
in or omissions from the Registration Statement and the Rule 462(b) Registration
Statement, if any, the Prospectus or the Disclosure Package made in
A-3
reliance upon and in conformity with information furnished to the Company in writing
by the Underwriters expressly for use in the Registration Statement and the Rule
462(b) Registration Statement, if any, the Prospectus or the Disclosure Package.
(d) The documents incorporated by reference in the Prospectus or the Disclosure
Package, at the time they were or hereafter are filed with the Commission, complied
or when so filed will comply, as the case may be, in all material respects with the
requirements of the 1934 Act and the rules and regulations of the Commission
promulgated thereunder (the “1934 Act Regulations”), and, when read together and
with the other information in the Disclosure Package and the Prospectus, did not and
will not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were or are made, not
misleading.
(e) The accountants who certified the financial statements and any supporting
schedules thereto included or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus are independent public
accountants with respect to the Company as required by the 1933 Act and the 1933 Act
Regulations.
(f) The financial statements, and the related notes thereto, and any supporting
schedules of the Company and its subsidiaries included or incorporated by reference
in the Registration Statement, the Disclosure Package and the Prospectus present
fairly the consolidated financial position of the Company and its subsidiaries as of
the dates indicated and the consolidated results of their operations for the periods
specified; except as stated therein, said financial statements have been prepared in
conformity with U.S. generally accepted accounting principles applied on a
consistent basis; the supporting schedules included or incorporated by reference in
the Registration Statement, the Disclosure Package and the Prospectus present fairly
the information required to be stated therein; and the pro forma financial
statements and the related notes thereto, if any, included or incorporated by
reference in the Registration Statement, the Disclosure Package and the Prospectus
present fairly the information shown therein, have been prepared in accordance with
the Commission’s rules and guidelines with respect to pro forma financial statements
and have been properly compiled on the bases described therein, and the assumptions
used in the preparation thereof are reasonable and the adjustments used therein are
appropriate to give effect to the transactions and circumstances referred to
therein.
(g) The petroleum engineers who have consented to being named as having reviewed
certain reserve data included or incorporated by reference in the Disclosure Package
and the Prospectus are independent engineers with respect to the Company and its
subsidiaries.
A-4
(h) This Agreement and the applicable Delayed Delivery Contracts (as defined below),
if any, have been duly authorized, executed and delivered by the Company and, upon
execution and delivery by the Underwriters, will be valid and legally binding
agreements of the Company; the Indenture has been duly authorized, executed and
delivered by the Company and, assuming due authorization, execution and delivery by
the Trustee, is a valid and legally binding agreement of the Company enforceable in
accordance with its terms, except as enforceability thereof may be limited by
bankruptcy, insolvency, reorganization, moratorium and other laws relating to or
affecting creditors’ rights generally and by general equity principles, and except
further as enforceability thereof may be limited by (1) requirements that a claim
with respect to any Debt Securities denominated other than in U.S. dollars (or a
foreign currency or composite currency judgment in respect of such claim) be
converted into U.S. dollars at a rate of exchange prevailing on a date determined
pursuant to applicable law or (2) governmental authority to limit, delay or prohibit
the making of payments outside the United States. The Offered Securities have been
duly and validly authorized for issuance, offer and sale pursuant to this Agreement
and each Delayed Delivery Contract, if any, and when issued, authenticated and
delivered pursuant to the provisions of this Agreement and the Indenture against
payment of the consideration therefor, the Offered Securities will constitute valid
and legally binding obligations of the Company enforceable in accordance with their
terms, except as enforceability thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium and other laws relating to or affecting enforcement of
creditors’ rights generally and by general equity principles, and except further as
enforceability thereof may be limited by (1) requirements that a claim with respect
to any Offered Securities denominated other than in U.S. dollars (or a foreign
currency or composite currency judgment in respect of such claim) be converted into
U.S. dollars at a rate or exchange prevailing on a date determined pursuant to
applicable law or (2) governmental authority to limit, delay or prohibit the making
of payments outside the United States. The Offered Securities and the Indenture
will be substantially in the form heretofore delivered to the Underwriters and
conform in all material respects to all statements relating thereto contained in the
Disclosure Package and the Prospectus; and each Holder (as defined in the Indenture)
of Offered Securities will be entitled to the benefits of the Indenture.
(i) Since the respective dates as of which information is given in the Registration
Statement, any Rule 462(b) Registration Statement, the Disclosure Package and the
Prospectus, except as may otherwise be stated therein or contemplated thereby, (1)
there has been no material adverse change in the condition, financial or otherwise,
or in the results of operations, business affairs or business prospects of the
Company and its subsidiaries considered as one enterprise, whether or not arising in
the ordinary course of business and (2) there have been no material transactions
entered into by the Company or any of its subsidiaries other than those in the
ordinary course of business.
A-5
(j) Neither the Company nor any of its subsidiaries is in violation of its charter
or by-laws or in default in the performance or observance of any material
obligation, agreement, covenant or condition contained in any contract, indenture,
mortgage, loan agreement, note, lease or other instrument to which it is a party or
by which it or any of them or their properties may be bound, where the consequences
of such violation or default would have a material adverse effect on the condition,
financial or otherwise, or the results of operations, business affairs or business
prospects of the Company and its subsidiaries considered as one enterprise; and the
execution and delivery of this Agreement, each Delayed Delivery Contract, if any,
and the Indenture and the consummation of the transactions contemplated herein and
therein have been duly authorized by all necessary corporate action of the Company
and will not conflict with or constitute a breach of, or default under, or result in
the creation or imposition of any lien, charge or encumbrance upon any property or
assets of the Company or any of its subsidiaries pursuant to, any contract,
indenture, mortgage, loan agreement, note, lease or other instrument to which the
Company or any of its subsidiaries is a party or by which it or any of them may be
bound or to which any of the property or assets of the Company or any subsidiary
thereof is subject, nor will such action result in any violation of the provisions
of the charter or by-laws of the Company or any law, administrative regulation or
administrative or court order or decree, where the consequences of such conflict,
breach, creation, imposition, violation or default would have a material adverse
effect on the condition, financial or otherwise, or the results of operations,
business affairs or business prospects of the Company and its subsidiaries
considered as one enterprise.
(k) No consent, approval, authorization, order, decree, registration or
qualification of or with any court or governmental agency or body is required for
the consummation by the Company of the transactions contemplated by this Agreement
or in connection with the sale of Offered Securities hereunder, except such as have
been obtained or rendered, as the case may be, or as may be required under state
securities laws (“Blue Sky”).
(l) Except as may be included or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus, there is no action, suit or
proceeding before or by any court or governmental agency or body, domestic or
foreign, now pending or, to the knowledge of the Company, threatened against or
affecting the Company or any of its subsidiaries which might, in the opinion of the
Company, result in any material adverse change in the condition, financial or
otherwise, or in the results of operations, business affairs or business prospects
of the Company and its subsidiaries considered as one enterprise, or could
reasonably be expected to materially and adversely affect the properties or assets
thereof or could reasonably be expected to materially and adversely affect the
consummation of this Agreement or the Indenture or any transaction contemplated
hereby or thereby.
(m) There are no contracts or documents of the Company or any of its subsidiaries
which are required to be filed as exhibits to the Registration
A-6
Statement by the 1933 Act or by the 1933 Act Regulations which have not been so
filed.
(n) Neither the Company nor any of its subsidiaries is in violation of any law,
ordinance, governmental rule or regulation or court decree to which it may be
subject or has failed to obtain any license, permit, franchise or other governmental
authorization necessary to the ownership of its property or to the conduct of its
business, which violation or failure would materially adversely affect the
condition, financial or otherwise, or the results of operations, business affairs or
business prospects of the Company and its subsidiaries considered as one enterprise;
and the Company and its subsidiaries own or possess or have obtained all
governmental licenses, permits, consents, orders, approvals and other authorizations
and have properly filed with the appropriate authorities all notices, applications
and other documents necessary to lease or own their respective properties and to
carry on their respective businesses as presently conducted, except where the
failure to possess such licenses or authorizations or make such filings would not
materially adversely affect the condition, financial or otherwise, or the results of
operations, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise.
(o) The Company and its subsidiaries own or possess, or can acquire on reasonable
terms, adequate trademarks, service marks and trade names necessary to conduct the
business now operated by them, except as set forth or incorporated by reference in
the Registration Statement, the Disclosure Package and the Prospectus, or except
where the failure to own or possess the same would not materially adversely affect
the condition, financial or otherwise, or the results of operations, business
affairs or business prospects of the Company and its subsidiaries considered as one
enterprise, and neither the Company nor any of its subsidiaries has received any
notice of infringement of or conflict with asserted rights of others with respect to
any trademarks, service marks or trade names which, singly or in the aggregate, if
the subject of an unfavorable decision, ruling or finding, would materially
adversely affect the condition, financial or otherwise, or the results of
operations, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise.
(p) The Company and its subsidiaries have legal, valid and defensible title to all
of their interests in oil and gas properties and to all other real and personal
property owned by them and any other real property and buildings held under lease by
the Company and its subsidiaries are held by them under valid, subsisting and
enforceable leases, in each case free and clear of all mortgages, pledges, liens,
security interests, claims, restrictions or encumbrances and defects of any kind,
except such as (1) are described in the Disclosure Package and the Prospectus, (2)
liens and encumbrances under operating agreements, unitization and pooling
agreements, production sales contracts, farm-out agreements and other oil and gas
exploration and production agreements, in each case that secure payment of amounts
not yet due and payable for the performance of other inchoate obligations and are of
a scope and nature customary in connection with similar
A-7
drilling and producing operations or (3) those that do not have a material adverse
effect on the condition, financial or otherwise, or the results of operations,
business affairs or business prospects of the Company and its subsidiaries
considered as one enterprise.
(q) The information underlying the estimates of oil and gas reserves as described in
the Disclosure Package and the Prospectus is complete and accurate in all material
respects (or, with regard to any information underlying the estimates prepared by
any petroleum engineers retained by the seller of such oil and gas reserves, is, to
the best knowledge of the Company after reasonable investigation, complete and
accurate in all material respects); other than production of the reserves in the
ordinary course of business and intervening product price fluctuations described in
the Disclosure Package and the Prospectus, the Company is not aware of any facts or
circumstances that would result in a material adverse change in the reserves or the
present value of future net cash flows therefrom as described in the Disclosure
Package and the Prospectus. Estimates of such reserves and present values comply
in all material respects with the applicable requirements of Regulation S-X and
Industry Guide 2 under the 1933 Act.
(r) Neither the Company nor any of its subsidiaries is required to be registered
under the Investment Company Act of 1940, as amended (the “1940 Act”).
(s) Except as described in the Registration Statement, the Prospectus and the
Disclosure Package, (1) neither the Company nor any of its subsidiaries is in
violation of any local or foreign laws or regulations relating to pollution or
protection of human health, the environment (including, without limitation, ambient
air, surface water, groundwater, land surface or subsurface strata) or wildlife,
including, without limitation, laws and regulations relating to the release or
threatened release of chemicals, pollutants, contaminants, wastes, toxic substances,
hazardous substances, petroleum or petroleum products (collectively, “Hazardous
Materials”) or to the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling of Hazardous Materials (collectively,
“Environmental Laws”), except such violations as would not, singly or in the
aggregate, have a material adverse effect on the condition, financial or otherwise,
or the results of operations, business affairs or business prospects of the Company
and its subsidiaries considered as one enterprise, and (2) to the best of the
Company’s knowledge, there are no events or circumstances that could reasonably be
expected to be the basis of an order for clean-up or remediation, or an action, suit
or proceeding by any private party or governmental body or agency, against or
affecting the Company or any of its subsidiaries relating to any Hazardous Materials
or the violation of any Environmental Laws, which, singly or in the aggregate, could
reasonably be expected to have a material adverse effect on the condition, financial
or otherwise, or the results of operations, business affairs or business prospects
of the Company and its subsidiaries considered as one enterprise.
A-8
(t) No relationship, direct or indirect, exists between or among the Company or any
of its subsidiaries on the one hand, and the directors, officers, stockholders,
customers or suppliers of the Company or any of its subsidiaries on the other hand,
which is required by the 1933 Act to be described in the Registration Statement, the
Prospectus and the Disclosure Package and which is not so described.
(u) (i) At the earliest time after the filing of the Registration Statement relating
to the Offered Securities that the Company or another offering participant made a
bona fide offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations)
and (ii) as of the date of the execution and delivery of the applicable Terms
Agreement (with such date being used as the determination date for purposes of this
clause (ii)), the Company was not and is not an Ineligible Issuer (as defined in
Rule 405 of the 1933 Act Regulations).
(v) Neither any Issuer Free Writing Prospectus nor the Final Term Sheet, as of its
issue date and at all subsequent times through the completion of any offering of
Offered Securities or until any earlier date that the Company notified or notifies
the Representatives as described in the next sentence, did not, does not and will
not include any information that conflicted, conflicts or will conflict with the
information contained in the Registration Statement, including any document
incorporated by reference therein that has not been superseded or modified. If at
any time following issuance of an Issuer Free Writing Prospectus there occurred or
occurs an event or development as a result of which such Issuer Free Writing
Prospectus conflicted or would conflict with the information contained in the
Registration Statement, the Company has promptly notified or will promptly notify
the Representatives and has promptly amended or supplemented or will promptly amend
or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate
or correct such conflict. The foregoing two sentences do not apply to statements in
or omissions from any Issuer Free Writing Prospectus based upon and in conformity
with written information furnished to the Company by any Underwriter expressly for
use therein.
(w) The Company has not distributed and will not distribute, prior to the later of
the Closing Time and the completion of the Underwriters’ distribution of the Offered
Securities, any offering material in connection with the offering and sale of any
Offered Securities other than a Preliminary Prospectus, the Prospectus, any Issuer
Free Writing Prospectus reviewed and consented to by the Representatives and
included in Schedule 1 to the applicable Terms Agreement, or the Registration
Statement.
(x) The Company maintains (i) effective internal control over financial reporting as
defined in Rule 13a-15 of the 1934 Act Regulations, and (ii) a system of internal
accounting controls sufficient to provide reasonable assurance that (A) transactions
are executed in accordance with management’s general or specific authorizations; (B)
transactions are recorded as necessary to permit preparation of financial statements
in conformity with generally accepted
A-9
accounting principles and to maintain asset accountability; (C) access to assets is
permitted only in accordance with management’s general or specific authorization;
and (D) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any
differences.
(y) Except as disclosed in the Disclosure Package and the Prospectus, or in any
document incorporated by reference therein, since the end of the Company’s most
recent audited fiscal year, there has been (i) no material weakness in the Company’s
internal control over financial reporting (whether or not remediated) and (ii) no
change in the Company’s internal control over financial reporting that has
materially affected, or is reasonably likely to materially affect, the Company’s
internal control over financial reporting.
Any certificate signed by any director or officer of the Company and delivered to the
Representatives or to counsel for the Underwriters shall be deemed a representation and warranty by
the Company as to the matters covered thereby.
SECTION 2. Purchase and Sale.
(a) The several commitments of the Underwriters to purchase the Offered Securities pursuant to
this Agreement shall be deemed to have been made on the basis of the representations and warranties
herein contained and shall be subject to the terms and conditions herein and therein set forth.
Offered Securities which are subject to Delayed Delivery Contracts are herein sometimes referred to
as “Delayed Delivery Offered Securities” and Offered Securities which are not subject to Delayed
Delivery Contracts are herein sometimes referred to as “Immediate Delivery Offered Securities”.
(b) In addition, on the basis of the representations and warranties herein contained and
subject to the terms and conditions herein set forth, the Company may grant, if so provided in the
Terms Agreement, an option to the Underwriters named in the Terms Agreement, severally and not
jointly, to purchase up to the principal amount of Option Securities set forth therein at the same
price per security (plus, except as otherwise provided in the Terms Agreement, interest, if any,
accrued and unpaid from the Closing Time until the applicable Date of Delivery), as is applicable
to the Offered Securities. Such option, if granted, will expire 30 days after the date of the
Terms Agreement, and may be exercised in whole or in part from time to time only for the purpose of
covering over-allotments which may be made in connection with the offering and distribution of the
Offered Securities upon notice by the Representatives to the Company setting forth the principal
amount of Option Securities as to which the several Underwriters are then exercising the option and
the time and date of payment and delivery for such Option Securities. Any such time and date of
delivery (a “Date of Delivery”) shall be determined by the Representatives, but shall not be later
than seven full business days and not earlier than two full business days after the exercise of
said option, nor in any event prior to the Closing Time, as hereinafter defined, unless otherwise
agreed upon by the Representatives and the Company. If the option is exercised as to all or any
portion of the Option Securities, each of the Underwriters, acting severally and not jointly, will
purchase the proportion of the total principal amount of Option Securities then being purchased
that the principal amount of
A-10
Immediate Delivery Offered Securities each such Underwriter has agreed to purchase, as set
forth in the Terms Agreement, bears to the total principal amount of Immediate Delivery Offered
Securities, subject to such adjustments as the Representatives in their discretion shall make to
eliminate any sales or purchases in less than authorized denominations.
(c) Payment of the purchase price for, and delivery of, the Immediate Delivery Offered
Securities to be purchased by the Underwriters shall be made at the place set forth in the Terms
Agreement, or at such other place as shall be agreed upon by the Representatives and the Company,
on the third business day (unless postponed in accordance with the provisions of Section 10)
following the date of the Terms Agreement or such other time as shall be agreed upon by the
Underwriters and the Company (such time and date being referred to as the “Closing Time”). Except
as specified in the Terms Agreement, payment shall be made to the Company by wire transfer in same
day funds to the account of the Company specified in the Terms Agreement against delivery to the
Underwriters for the respective accounts of the Underwriters of the Immediate Delivery Offered
Securities to be purchased by them (unless the Offered Securities are issuable only in the form of
one or more global instruments registered in the name of a depository or a nominee of a depository,
in which event the Underwriters’ interest in such global instrument shall be noted in a manner
satisfactory to the Underwriters and their counsel). In addition, in the event that any or all of
the Option Securities are purchased by the Underwriters, payment of the purchase price for, and
delivery of certificates representing, such Option Securities shall be made at such place as shall
be agreed upon by the Representatives and the Company, on each Date of Delivery as agreed by the
Representatives and the Company. The Immediate Delivery Offered Securities shall be in such
denominations and registered in such names as the Underwriters may request in writing at least two
business days prior to the Closing Time or relevant Date of Delivery, as the case may be. The
Immediate Delivery Offered Securities, which if agreed by the Representatives may be in temporary
form, will be made available for examination and packaging by the Representatives on or before the
first business day prior to the Closing Time or relevant Date of Delivery, as the case may be.
(d) If authorized by the Terms Agreement, the Underwriters named therein may solicit offers to
purchase Offered Securities from the Company pursuant to delayed delivery contracts (“Delayed
Delivery Contracts”) substantially in the form of Exhibit B hereto, with such changes therein as
the Company may approve. As compensation for arranging Delayed Delivery Contracts, the Company
will pay to the Representatives at the Closing Time, for the account of the Underwriters, a fee
equal to that percentage of the aggregate principal amount of Delayed Delivery Offered Securities
for which Delayed Delivery Contracts are made at the Closing Time as is specified in the Terms
Agreement. Any Delayed Delivery Contracts are to be with institutional investors of the types set
forth in the Prospectus Supplement. At the Closing Time the Company will enter into Delayed
Delivery Contracts (for not less than the minimum principal amount of Delayed Delivery Offered
Securities per Delayed Delivery Contract specified in the Terms Agreement) with all purchasers
proposed by the Underwriters and previously approved by the Company as provided below, but not for
an aggregate principal amount of Offered Securities in excess of that specified in the Terms
Agreement. The Underwriters will not have any responsibility for the validity or performance of
Delayed Delivery Contracts.
A-11
(e) The Representatives are to submit to the Company, at least two business days prior to the
Closing Time, the names of any institutional investors with which it is proposed that the Company
will enter into Delayed Delivery Contracts and the principal amount of Delayed Delivery Offered
Securities to be purchased by each of them, and the names of the institutions with which the making
of Delayed Delivery Contracts is approved by the Company and the principal amount of Delayed
Delivery Offered Securities to be covered by each such Delayed Delivery Contract.
(f) The principal amount of Offered Securities agreed to be purchased by the respective
Underwriters pursuant to this Agreement shall be reduced by the principal amount of Delayed
Delivery Offered Securities covered by Delayed Delivery Contracts, as to each Underwriter as set
forth in a written notice delivered by the Underwriters to the Company; provided, however, that the
total principal amount of Immediate Delivery Offered Securities to be purchased by all Underwriters
shall be the total amount of the Offered Securities covered by this Agreement, less the total
principal amount of Delayed Delivery Offered Securities covered by Delayed Delivery Contracts.
SECTION 3. Covenants of the Company. The Company covenants with each
Underwriter as follows:
(a) Immediately following the execution of the Terms Agreement, the Company will
prepare a Prospectus Supplement in form approved by the Representatives setting
forth the principal amount of Offered Securities and their terms not otherwise
specified in the Indenture, if applicable, the names of the Underwriters and the
principal amount of the Offered Securities which each severally has agreed to
purchase, the names of the Underwriters, the price at which the Offered Securities
are to be purchased by the Underwriters from the Company, the initial public
offering price, the selling concession and reallowance, if any, any delayed delivery
arrangements, and such other information as the Representatives and the Company deem
appropriate in connection with the offering of the Offered Securities. The Company
will promptly transmit copies of the Prospectus Supplement to the Commission for
filing pursuant to Rule 424 of the 1933 Act Regulations and will furnish to the
Underwriters named therein as many copies of the Prospectus (including the
Prospectus Supplement) as the Representatives shall reasonably request.
(b) If at any time when the Prospectus is required by the 1933 Act to be delivered
in connection with sales of the Offered Securities, including in circumstances where
such requirement may be satisfied pursuant to Rule 172 of the 1933 Act Regulations,
any event shall occur or condition exist as a result of which it is necessary, in
the opinion of counsel for the Underwriters or counsel for the Company, to amend or
supplement the Disclosure Package or the Prospectus in order that Disclosure Package
or the Prospectus, as the case may be, will not include an untrue statement of a
material fact or omit to state any material fact necessary in order to make the
statements therein not misleading in the light of the circumstances existing at the
Applicable Time, in the case of the Disclosure Package, or at the time the
Prospectus is delivered to a purchaser, in the case of
A-12
the Prospectus, or if it shall be necessary, in the opinion of either such counsel,
to amend or supplement the Registration Statement, the Disclosure Package or the
Prospectus in order to comply with the requirements of the 1933 Act or the 1933 Act
Regulations, the Company will promptly amend the Registration Statement, the
Disclosure Package or the Prospectus, as the case may be, whether by filing
documents pursuant to the 1934 Act or the 1933 Act or otherwise, as may be necessary
to correct such untrue statement or omission or to make the Registration Statement,
the Disclosure Package or the Prospectus, as the case may be, comply with such
requirements.
(c) The Company will make generally available to its security holders as soon as
practicable, but not later than 90 days after the close of the period covered
thereby, an earnings statement (in form complying with the provisions of Rule 158 of
the 1933 Act Regulations) covering each twelve month period beginning, in each case,
not later than the first day of the Company’s fiscal quarter next following the
“effective date” (as defined in such Rule 158) of the Registration Statement with
respect to each sale of Offered Securities.
(d) While the Prospectus is required by the 1933 Act to be delivered in connection
with sales of the Offered Securities, including in circumstances where such
requirement may be satisfied pursuant to Rule 172 of the 1933 Act Regulations, the
Company will give the Representatives notice of its intention to file any additional
registration statement with respect to the registration of additional Debt
Securities, any amendment to the Registration Statement (including any filing under
Rule 462(b)) or any amendment or supplement to the Prospectus or, after the
Applicable Time, the Disclosure Package, whether pursuant to the 1934 Act, the 1933
Act or otherwise; will furnish the Underwriters with copies of any such amendment or
supplement or other documents proposed to be filed a reasonable time in advance of
such proposed filing or use, as the case may be; and will not file any such
amendment or supplement or other documents in a form to which the Representatives or
counsel to the Underwriters reasonably object.
(e) While the Prospectus is required by the 1933 Act to be delivered in connection
with sales of the Offered Securities, including in circumstances where such
requirement may be satisfied pursuant to Rule 172 of the 1933 Act Regulations, the
Company will notify the Representatives immediately, and promptly confirm the notice
in writing, of (i) the effectiveness of any amendment to the Registration Statement,
(ii) the transmittal to the Commission for filing of any supplement to the
Prospectus or any document to be filed pursuant to the 1934 Act which will be
incorporated by reference into the Registration Statement, the Prospectus or any
Preliminary Prospectus, (iii) the receipt of any comments from the Commission with
respect to the Registration Statement, the Prospectus, any Preliminary Prospectus or
the Prospectus Supplement, (iv) any request by the Commission for any amendment to
the Registration Statement, or any amendment or supplement to the Prospectus or any
Preliminary Prospectus or for additional information, (v) the issuance by the
Commission of any stop order suspending the
A-13
effectiveness of the Registration Statement or the initiation of any proceedings for
that purpose and (vi) any change in the rating assigned by any nationally recognized
statistical rating organization to any debt securities of the Company or the public
announcement by any nationally recognized statistical rating organization that it
has under surveillance or review, with possible negative implications, its rating of
any debt securities of the Company. The Company will make every reasonable effort
to prevent the issuance of any stop order and, if any stop order is issued, to
obtain the lifting thereof at the earliest possible moment.
(f) The Company will deliver to each Underwriter one conformed copy of the
Registration Statement (as originally filed) and of each amendment thereto
(including exhibits filed therewith or incorporated by reference therein and
documents incorporated by reference in the Prospectus) and will also deliver to the
Representatives as many conformed copies of the Registration Statement as originally
filed and of each amendment thereto (without exhibits) as the Representatives may
reasonably request. While the Prospectus is required by the 1933 Act to be
delivered in connection with sales of the Offered Securities, including in
circumstances where such requirement may be satisfied pursuant to Rule 172 of the
1933 Act Regulations, the Company will furnish to the Representatives as many copies
of the Prospectus (including the Prospectus Supplement) as the Representatives
reasonably request.
(g) The Company will endeavor, in cooperation with the Underwriters, to qualify the
Offered Securities for offering and sale under the applicable securities laws of
such states and other jurisdictions of the United States as the Underwriters may
designate, and will maintain such qualifications in effect for as long as may be
required for the distribution of the Offered Securities; provided,
however, that the Company shall not be obligated to file any general consent
to service of process or to qualify as a foreign corporation in any jurisdiction in
which it is not so qualified. The Company will file such statements and reports as
may be required by the laws of each jurisdiction in which the Offered Securities
have been qualified as above provided. The Company will promptly advise the
Representatives of the receipt by the Company of any notification with respect to
the suspension of the qualification of the Offered Securities for sale in any such
state or jurisdiction or the initiating or threatening of any proceeding for such
purpose.
(h) The Company, during the period when the Prospectus is required to be delivered
under the 1933 Act or the 1934 Act in connection with sales of the Offered
Securities, including in circumstances where such requirement may be satisfied
pursuant to Rule 172 of the 1933 Act Regulations, will file all documents required
to be filed with the Commission pursuant to Section 13, 14 or 15(d) of the 1934 Act
within the time periods prescribed by the 1934 Act and the 1934 Act Regulations.
(i) If specified in the Terms Agreement, between the date of the Terms Agreement and
the completion of the distribution of the Offered Securities or the
A-14
Closing Time, whichever is later, or such other time as is specified in the Terms
Agreement, the Company will not, without the prior written consent of the
Representatives, offer or sell, grant any option for the sale of, or enter into any
agreement to sell, any debt securities of the Company substantially similar to the
Offered Securities (other than the Offered Securities that are to be sold pursuant
to such agreement or commercial paper in the ordinary course of business).
(j) The Company will prepare a final term sheet containing only a description of the
Offered Securities, in a form approved by the Representatives, and will file such
final term sheet pursuant to Rule 433(d) of the 1933 Act Regulations within the time
required by such rule (such term sheet, the “Final Term Sheet”).
(k) The Company represents that it has not made, and agrees that, unless it obtains
the prior written consent of the Representatives, it will not make, any offer
relating to the Offered Securities that would constitute an Issuer Free Writing
Prospectus or that would otherwise constitute a “free writing prospectus” (as
defined in Rule 405 of the 1933 Act Regulations) required to be filed by the Company
with the Commission or retained by the Company under Rule 433 of the 1933 Act
Regulations; provided that the prior written consent of the Representatives hereto
shall be deemed to have been given in respect of the Free Writing Prospectuses
included in Schedule 1 to the applicable Terms Agreement. Any such free writing
prospectus consented to by the Representatives is hereinafter referred to as a
“Permitted Free Writing Prospectus”. The Company agrees that (i) it has treated and
will treat, as the case may be, each Permitted Free Writing Prospectus as an Issuer
Free Writing Prospectus, and (ii) has complied and will comply, as the case may be,
with the requirements of Rules 164 and 433 of the 1933 Act Regulations applicable to
any Permitted Free Writing Prospectus, including in respect of timely filing with
the Commission, legending and record keeping. The Company consents to the use by
any Underwriter of a free writing prospectus that (a) is not an “issuer free writing
prospectus” as defined in Rule 433 of the 1933 Act Regulations, and (b) contains
only (i) information describing the preliminary terms of the Offered Securities or
their offering, (ii) information permitted by Rule 134 of the 1933 Act Regulations
or (iii) information that describes the final terms of the Offered Securities or
their offering and that is included in the Final Term Sheet of the Company
contemplated in Section 3(j) of this Agreement.
(l) If immediately prior to the third anniversary (the “Renewal Deadline”) of
December 1, 2005, any of the Offered Securities remain unsold by the Underwriters,
the Company will prior to the Renewal Deadline file, if it has not already done so
and is eligible to do so, a new shelf registration statement relating to the Offered
Securities, in a form satisfactory to the Representatives, and will use its best
efforts to cause such registration statement to be declared effective within 60 days
after the Renewal Deadline. The Company will take all other action necessary or
appropriate to permit the public offering and sale of the Offered Securities to
continue as contemplated in the expired registration
A-15
statement relating to the Offered Securities. References herein to the Registration
Statement shall include such new shelf registration statement.
SECTION 4. Conditions of Underwriters’ Obligations. The obligations of the
Underwriters to purchase Offered Securities pursuant to this Agreement are subject to the
accuracy of the representations and warranties on the part of the Company herein contained,
to the accuracy of the statements which the Company’s officers made in any certificate
furnished pursuant to the provisions hereof, to the performance by the Company of all of its
covenants and other obligations hereunder and under the Terms Agreement, and to the
following further conditions:
(a) At the Closing Time, no stop order suspending the effectiveness of the
Registration Statement or any Rule 462(b) Registration Statement shall have been
issued under the 1933 Act or proceedings therefor initiated or threatened by the
Commission.
(b) At the Closing Time, the Representatives shall have received:
(1) The favorable opinion, dated as of the Closing Time, of Xxxxxxx Xxxxx LLP,
counsel to the Company, to the effect that:
(i) The Company is validly existing as a corporation in good standing under the
laws of the State of Delaware. The Company has the corporate power and authority to
own, lease and operate its properties and to conduct its business as described in
the Disclosure Package and the Prospectus and to enter into and perform its
obligations under this Agreement and the Delayed Delivery Contracts, if any. To the
best knowledge and information of such counsel, the Company is qualified as a
foreign corporation to transact business and is in good standing in the State of
Texas and in each other U.S. jurisdiction listed in such opinion.
(ii) Each Significant Subsidiary is validly existing as a corporation or other
business organization in good standing under the laws of the jurisdiction of its
formation or organization, has the corporate or other entity power and authority to
own, lease and operate its properties and conduct its business as described in the
Disclosure Package and the Prospectus and, to the best of such counsel’s knowledge
and information, is qualified as a foreign corporation to transact business and is
in good standing in each U.S. jurisdiction listed in such opinion; and all of the
issued and outstanding capital stock of each Significant Subsidiary has been duly
authorized and validly issued, is fully paid and nonassessable, and to our knowledge
is owned of record by the Company, directly or indirectly, free and clear of any
mortgage, pledge, lien, encumbrance, claim or equity (except as described in the
Disclosure Package and the Prospectus); provided, however, that in respect of Apache
North Sea Limited (“Apache NS”), as to its good standing in any jurisdiction, we
opine only that no action is currently being taken by Registrar of Companies of
England and Wales for striking Apache NS off the register and dissolving it as
defunct, and as far as
A-16
such Registrar is aware Apache NS is not in liquidation or subject to
administrative order and no receiver or manager of Apache NS’s property has been
appointed; and as to the Company’s ownership of shares of Apache NS, that all
ordinary shares of Apache NS are owned by Apache North Sea Investment (“ANSI”) and
no charges or mortgages have been registered in Apache NS’s or ANSI’s register of
charges at Companies’ House.
(iii) This Agreement has been duly authorized, executed and delivered by the
Company.
(iv) The Indenture has been duly authorized, executed and delivered by the
Company and (assuming the Indenture has been duly authorized, executed and delivered
by the Trustee) constitutes a valid and legally binding agreement of the Company,
enforceable in accordance with its terms under applicable laws of the State of New
York.
(v) The Offered Securities, in the form(s) certified by the Company as of the
Closing Time, have been duly and validly authorized for issuance, offer and sale
pursuant to this Agreement and, when issued, authenticated and delivered pursuant to
the provisions of this Agreement, any Delayed Delivery Contract and the Indenture
against payment of the consideration therefor, will constitute valid and legally
binding obligations of the Company, enforceable in accordance with their terms under
applicable laws of the State of New York; and each holder of Offered Securities will
be entitled to the benefits of the Indenture.
(vi) The Offered Securities and the Indenture conform in all material respects
to the statements relating thereto in the Disclosure Package and the Prospectus; and
the statements in the Disclosure Package and the Prospectus under the captions
“Description of Notes” and “Description of Debt Securities”, insofar as they purport
to summarize certain provisions of documents specifically referred to therein,
fairly summarize the matters referred to therein in all material respects.
(vii) The Indenture has been duly qualified under the 1939 Act.
(viii) The Registration Statement, including any Rule 462(b) Registration
Statement, has been declared effective by the Commission under the 1933 Act and, to
the best of such counsel’s knowledge, no stop order suspending the effectiveness of
the Registration Statement or any Rule 462(b) Registration Statement has been issued
under the 1933 Act or proceedings therefor initiated or threatened by the
Commission.
(ix) The Registration Statement, including any Rule 462(b) Registration
Statement, and the Prospectus (except for financial statements and engineering
reports and other financial or engineering data, and except for those parts of the
Registration Statement that constitute the Form T-1, as to which such
A-17
counsel need not express any opinion), as of their respective effective or
issue dates, appeared on their face to be in all material respects appropriately
responsive to the requirements of the 1933 Act and the 1933 Act Regulations.
(x) The statements contained in the Disclosure Package and the Prospectus under
the heading “Material United States Federal Income Tax Considerations”, or similar
heading, to the extent that they constitute matters of U.S. federal income tax law
or legal conclusions with respect thereto, are correct in all material respects.
(xi) Neither the Company nor any Significant Subsidiary is required to be
registered under the 1940 Act.
(xii) No consent, approval, authorization, order, decree, registration or
qualification of or with any court or governmental authority or agency under
applicable laws is required in connection with the consummation by the Company of
the transactions contemplated by this Agreement, any Delayed Delivery Contract or
the Indenture, except such as have been obtained or rendered, as the case may be, or
as may be required under the 1933 Act, the 1933 Act Regulations, the 1934 Act, the
1934 Act Regulations or state securities laws; and to the best knowledge and
information of such counsel, the execution and delivery of this Agreement, the
Delayed Delivery Contract, if applicable, and the Indenture and the performance by
the Company of its obligations set forth herein and therein will not in any material
respect conflict with or constitute a breach of, or default under, or result in the
creation or imposition of any lien, charge or encumbrance upon any property or
assets of the Company or any of its subsidiaries pursuant to, any specified contract
listed in such opinion; nor will such action result, in any material respect, in a
violation of the provisions of the charter or bylaws of the Company or any
applicable law or regulation, or, to the best knowledge and information of such
counsel, any administrative or order or decree specified or described in such
opinion.
(xiii) To the best of such counsel’s knowledge and information, other than in
respect of matters disclosed in the Registration Statement, the Prospectus or the
Disclosure Package, there is no action, suit or proceeding before or by any court or
governmental agency or body, domestic or foreign, now pending, or overtly threatened
against or affecting, the Company or any of its subsidiaries, which would be
reasonably expected to result in any material adverse change in the condition,
financial or otherwise, or in the results of operations or business affairs of the
Company and its subsidiaries considered as one enterprise, or would materially and
adversely affect the properties or assets thereof or would materially and adversely
affect the consummation of this Agreement, the Delayed Delivery Contracts, if
applicable, or the Indenture or any transaction contemplated hereby or thereby.
(xiv) Each document filed pursuant to the 1934 Act and incorporated by
reference in the Disclosure Package or the Prospectus (except for
A-18
exhibits, financial statements, supporting schedules or other financial or
statistical information as to which no opinion need be rendered) appeared on its
face to be appropriately responsive as to form when so filed to the requirements of
the 1934 Act and the 1934 Act Regulations.
In rendering such opinion, counsel for the Company may rely as to matters of fact upon the
representations of officers of the Company contained in any certificate delivered to such counsel
and certificates of public officials, which certificates shall be attached to or delivered with
such opinion. Such opinion shall be limited to the General Corporation Law of the State of
Delaware, the laws of the State of New York, the laws of the State of Texas and the laws of the
United States of America, and shall be further limited to applicable laws and regulations of such
jurisdictions that, in the experience of such counsel, are normally applicable to transactions of
the type contemplated by this Agreement, the Indenture and the Offered Securities. With respect to
the opinions set forth in Section 4(b)(1)(ii) above, such counsel may rely upon, and assume the
accuracy of, matters set forth in the opinions of counsel licensed in the jurisdiction in which
each such Significant Subsidiary is organized, and the language of such opinion may be conformed to
the language of such other opinions of local counsel. The opinion regarding enforceability
referred to in Sections 4(b)(1)(iv) and 4(b)(1)(v) above will be limited by bankruptcy, insolvency,
reorganization, moratorium and other laws relating to or affecting enforcement of creditors’ rights
generally and by general principles of equity, whether enforcement is sought at law or in equity.
Such opinion of counsel shall further be subject to customary assumptions, qualifications and
exceptions.
(2) The favorable opinion, dated as of the Closing Time, of Sidley Austin
LLP, counsel for the Underwriters, with respect to the matters set forth
in clauses (i) to (viii), inclusive, of subsection (b)(1) of this Section.
(3) In giving their opinions required by subsection (b)(1) and (b)(2),
respectively, of this Section 4, Xxxxxxx Xxxxx LLP and Sidley Austin
LLP shall each additionally state that in the course of the preparation
of the Registration Statement, the Disclosure Package and the Prospectus such
counsel has considered the information set forth therein in light of the matters
required to be set forth therein, and has participated in conferences with officers
and representatives of the Company including its independent public accountants,
during the course of which the contents of the Registration Statement, the
Disclosure Package and the Prospectus and related matters were discussed. Such
counsel need not independently check the accuracy or completeness of, or otherwise
verify, and accordingly need not pass upon, and accordingly need not assume
responsibility for, the accuracy, completeness or fairness of the statements
contained in the Registration Statement, the Disclosure Package or the Prospectus
and such counsel may, in good faith, rely as to facts necessary to the determination
of materiality upon the judgment of officers and representatives of the Company.
Such counsel shall additionally state that, however, as a result of such
consideration and participation, nothing has come to such counsel’s attention which
causes such counsel to believe that (i) the Registration Statement, at the time it
became effective (or, if an amendment to the Registration Statement or an Annual
Report on Form 10-K has been filed by the Company with the
A-19
Commission subsequent to the effectiveness of the Registration Statement, then
at the time such amendment became effective or at the time of such filing, as the
case may be), or as of the “new effective date” with respect to the Underwriters
pursuant to, and within the meaning of, Rule 430(B)(f)(2) of the 1933 Act
Regulations, contained an untrue statement of a material fact or omitted to state a
material fact required to be stated therein or necessary in order to make the
statements therein not misleading; (ii) the Prospectus or any amendment or
supplement thereto, at the time the Prospectus was issued at the time any such
amendment or supplement was issued or, at the Closing Time included or includes an
untrue statement of a material fact or omitted or omits to state a material fact
necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; or (iii) the Disclosure Package, as of
the Applicable Time, contained any untrue statement of a material fact or omitted
to state any material fact necessary in order to make the statements therein, in the
light of circumstances under which they were made, not misleading (it being
understood that such counsel need not make any statement with respect to the
financial statements and engineering reports and other financial or engineering data
contained in the Registration Statement (including the Prospectus) or those parts of
the Registration Statement which constitute the Form T-1, or the Disclosure
Package).
(c) At the Closing Time, there shall not have been, since the date of the Terms
Agreement or since the respective dates as of which information is given in the
Registration Statement and the Prospectus, or in the Disclosure Package, any
material adverse change in the condition, financial or otherwise, or in the results
of operations, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise, whether or not arising in the ordinary
course of business, and the Representatives shall have received a certificate of the
Chief Executive Officer, President or Vice President and the Treasurer, the
Assistant Treasurer, the principal financial officer or principal accounting officer
of the Company, dated as of the Closing Time, to the effect that (i) there has been
no such material adverse change with respect to the Company and its subsidiaries,
(ii) the representations and warranties of the Company contained in Section 1 are
true and correct as of the Closing Time, (iii) the Company has performed or complied
with all agreements and satisfied all conditions on its part to be performed or
satisfied at or prior to the date of such certificate and (iv) no stop order
suspending the effectiveness of the Registration Statement or any Rule 462(b)
Registration Statement has been issued and no proceedings for that purpose have been
initiated or threatened by the Commission. As used in this Section 4(c), the term
“Prospectus” means the Prospectus in the form first provided to the applicable
Underwriter or Underwriters for use in confirming sales of the Offered Securities.
A-20
(d) (1) On the date of the Terms Agreement, the Underwriters shall have received a
letter from Ernst & Young LLP, dated as of the date thereof and in form
and substance satisfactory to the Underwriters, to the effect that:
(i) They are independent accountants with respect to the Company and its
subsidiaries within the meaning of the 1933 Act, the 1933 Act Regulations, the 1934
Act and the 1934 Act Regulations.
(ii) It is their opinion that the consolidated financial statements and
supporting schedule(s) included or incorporated by reference in the Registration
Statement and the Prospectus and audited by them and covered by their opinions
therein comply in form in all material respects with the applicable accounting
requirements of the 1933 Act, the 1933 Act Regulations, the 1934 Act and the 1934
Act Regulations.
(iii) In addition to the audit referred to in their opinion, they have
performed specified procedures, not constituting an audit, including a reading of
the latest available interim financial statements of the Company and its indicated
subsidiaries, a reading of the minute books of the Company and such subsidiaries
since the end of the most recent fiscal year with respect to which an audit report
has been issued, inquiries of and discussions with certain officials of the Company
and such subsidiaries responsible for financial and accounting matters with respect
to the latest available interim unaudited financial statements of the Company and
its subsidiaries, and such other inquiries and procedures as may be specified in
such letter and setting forth the results of such inquiries and procedures.
(2) At the Closing Time, the Underwriters shall have received from Xxxxx Xxxxx
LLP, a letter, dated as of the Closing Time, to the effect that they reaffirm the
statements made in the letter furnished pursuant to subsection (d)(1) of this
Section, except that the specified date referred to shall be a date not more than
three days prior to the Closing Time.
(e) At the Closing Time, counsel for the Underwriters shall have been furnished with
such documents and opinions as they may reasonably require for the purpose of
enabling them to pass upon the issuance and sale of the Offered Securities as herein
contemplated and related proceedings or in order to evidence the accuracy and
completeness of any of the representations and warranties, or the fulfillment of any
of the conditions, herein contained; and all proceedings taken by the Company in
connection with the issuance and sale of the Offered Securities as herein and in the
Terms Agreement contemplated shall be satisfactory in form and substance to the
Representatives.
(f) The Final Term Sheet, and any other material required to be filed by the Company
pursuant to Rule 433(d) of the 1933 Act Regulations, shall have been filed with the
Commission within the applicable time periods prescribed for such filings under such
Rule 433.
A-21
(g) If specified in the applicable Terms Agreement, at the time of execution of such
Terms Agreement, the Underwriters shall have received a signed letter, dated the
date of such Terms Agreement, in form and substance satisfactory to the
Underwriters, from Xxxxx Xxxxx Company, L.P.
(h) In the event that the Terms Agreement provides for Option Securities and the
Underwriters exercise their option pursuant to Section 2(b) hereof to purchase all
or any portion of the Option Securities, the representations and warranties of the
Company contained herein and the statements in any certificates furnished by the
Company hereunder shall be true and correct as of each Date of Delivery, and the
Underwriters shall have received:
(1) Unless the Date of Delivery is the Closing Time, a certificate, dated such
Date of Delivery, of the Chief Executive Officer, President or Vice President and
the Treasurer, the Assistant Treasurer, the principal financial officer or principal
accounting officer of the Company, in their capacities as such, confirming that the
certificate delivered at the Closing Time pursuant to Section 4(c) hereof remains
true and correct as of such Date of Delivery.
(2) The favorable opinion of Xxxxxxx Xxxxx LLP, counsel for the
Company, in form and substance satisfactory to counsel for the Underwriters, dated
such Date of Delivery, relating to the Option Securities and otherwise substantially
to the same effect as the opinions required by subsection (1) of Section 4(b)
hereof.
(3) The favorable opinion of Sidley Austin LLP, counsel for the
Underwriters, dated such Date of Delivery, relating to the Option Securities and
otherwise to the same effect as the opinion required by subsection (2) of Section
4(b) hereof.
Unless the Date of Delivery is the Closing Time, a letter from Ernst & Young
LLP, in form and substance satisfactory to the Underwriters and dated such Date of
Delivery, a substantially the same in scope and substance as the letter furnished to
the Underwriters at the Closing Time pursuant to Section 4(d)(2) hereof, except that
the “specified date” in the letter shall be a date not more than three days prior to
such Date of Delivery
If any condition specified in this Section shall not have been fulfilled when and as required
to be fulfilled, this Agreement may be terminated by the Representatives by notice to the Company
at any time at or prior to the Closing Time, and such termination shall be without liability of any
party to any other party except as provided in Section 5.
SECTION 5. Payment of Expenses. The Company will pay all expenses incident to
the performance of its obligations under this Agreement, including:
(a) the preparation and filing of the Registration Statement, including any Rule
462(b) Registration Statement, and all amendments thereto, the Prospectus
A-22
and any amendments or supplements thereto, any Preliminary Prospectus and any
Permitted Free Writing Prospectus;
(b) the preparation, filing and reproduction of this Agreement and the Delayed
Delivery Contract(s), if applicable;
(c) the preparation, printing, issuance and delivery of the Offered Securities,
including any fees and expenses relating to the eligibility and issuance of Offered
Securities in book-entry form;
(d) the fees and disbursements of the Company’s accountants and counsel, of the
Trustee and its counsel, and of any calculation agent or exchange rate agent;
(e) except as otherwise provided in the Terms Agreement, the reasonable fees and
disbursements of counsel to the Underwriters;
(f) the qualification of the Offered Securities under state securities laws in
accordance with the provisions of Section 3(k) hereof, including filing fees and the
reasonable fees and disbursements of counsel for the Underwriters in connection
therewith and in connection with the preparation of any Blue Sky Survey;
(g) the printing and delivery to the Underwriters in quantities as hereinabove
stated of copies of the Registration Statement and any amendments thereto, and of
the Prospectus and any amendments or supplements thereto, and the delivery by the
Underwriters of the Prospectus and any amendments or supplements thereto in
connection with solicitations or confirmations of sales of the Offered Securities;
(h) the preparation, reproducing and delivery to the Underwriters of copies of the
Indenture and all amendments, supplements and modifications thereto;
(i) any fees charged by nationally recognized statistical rating organizations for
the rating of the Offered Securities;
(j) the fees and expenses incurred in connection with any listing of Offered
Securities on a securities exchange;
(k) the fees and expenses incurred with respect to any filing with the National
Association of Securities Dealers, Inc.;
(l) any out-of-pocket expenses of the Underwriters incurred with the approval of the
Company; and
(m) the cost of providing any CUSIP or other identification numbers for the Offered
Securities.
A-23
If this Agreement is terminated by the Underwriters in accordance with the provisions of
Section 9, the Company shall reimburse the Underwriters for all of their out-of-pocket expenses,
including the reasonable fees and disbursements of counsel for the Underwriters.
SECTION 6. Indemnification. (a) The Company agrees to indemnify and hold
harmless each Underwriter and each person, if any, who controls any Underwriter within the
meaning of Section 15 of the 1933 Act as follows:
(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred,
arising out of any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement (or any amendment thereto), including any Rule 462(b)
Registration Statement, including information deemed to be part of the Registration
Statement pursuant to Rule 430B of the 1933 Act Regulations, or the omission or alleged
omission therefrom of a material fact required to be stated therein or necessary to make the
statements therein not misleading or arising out of any untrue statement or alleged untrue
statement of a material fact included in the Base Prospectus, any preliminary prospectus
supplement, any Issuer Free Writing Prospectus, the information contained in the Final Term
Sheet, or the Prospectus (or any amendment or supplement thereto) or the omission or alleged
omission therefrom of a material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading, unless such
untrue statement or omission or such alleged untrue statement or omission was made in
reliance upon and in conformity with written information furnished to the Company by an
Underwriter expressly for use in the Registration Statement (or any amendment thereto), the
Base Prospectus, such preliminary prospectus supplement, such Issuer Free Writing
Prospectus, such Final Term Sheet or the Prospectus (or any amendment or supplement
thereto);
(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred,
to the extent of the aggregate amount paid in settlement of any litigation, or investigation
or proceeding by any governmental agency or body, commenced or threatened, or of any claim
whatsoever based upon any such untrue statement or omission, or any such alleged untrue
statement or omission; provided that such settlement is effected with the written consent of
the Company, which consent shall not be unreasonably withheld; and
(iii) against any and all expense whatsoever, as incurred (including the fees and expenses
of counsel chosen by such Underwriter), reasonably incurred in investigating, preparing or
defending against any litigation, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue
statement or omission, or any such alleged untrue statement or omission, to the extent that
any such expense is not paid under (i) or (ii) above.
(b) Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the
Company, its directors, each of its officers who signed the Registration Statement, and each
person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act against
any and all loss, liability, claim, damage and expense described in the indemnity contained in
subsection (a) of this Section, but only with respect to untrue statements or omissions, or alleged
untrue statements or omissions, made in the Registration Statement (or any
A-24
amendment thereto), any Rule 462(b) Registration Statement, the Base Prospectus, any
preliminary prospectus supplement, any Issuer Free Writing Prospectus, the information contained in
the Final Term Sheet, or the Prospectus (or any amendment or supplement thereto) in reliance upon
and in conformity with written information furnished to the Company by such Underwriter expressly
for use in the Registration Statement (or any amendment thereto), any Rule 462(b) Registration
Statement, the Base Prospectus, such preliminary prospectus supplement, such Issuer Free Writing
Prospectus, such Final Term Sheet or the Prospectus (or any amendment or supplement thereto).
(c) Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought
hereunder, but failure to so notify an indemnifying party shall not relieve it from any liability
which it may have otherwise than on account of this indemnity agreement. If any such claim or
action shall be brought against an indemnified party, and it shall notify the indemnifying party
thereof, the indemnifying party shall be entitled to participate therein and to the extent that it
wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof
with counsel reasonably satisfactory to the indemnified party. After notice from the indemnifying
party to the indemnified party of its election to assume the defense of such claim or action, the
indemnifying party shall not be liable to the indemnified party under this Section for any legal or
other expenses subsequently incurred by the indemnified party in connection with the defense
thereof other than reasonable costs of investigation; provided, however, that each Underwriter
shall have the right to employ counsel to represent jointly the Underwriters and their respective
controlling persons who may be subject to liability arising out of any claim in respect of which
indemnity may be sought by the Underwriters against the Company under this Section if, in the
judgment of any of the Underwriters, it is advisable for such Underwriter or Underwriters and
controlling persons to be jointly represented by separate counsel, and in that event the fees and
expenses of such separate counsel shall be paid by the Company. In no event shall the indemnifying
parties be liable for the fees and expenses of more than one counsel (in addition to any local
counsel) separate from their own counsel for all indemnified parties in connection with any one
action or separate but similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances. No indemnifying party shall, without the prior written
consent of the indemnified parties (which shall not unreasonably be withheld), settle or compromise
or consent to the entry of any judgment with respect to any litigation, or any investigation or
proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in
respect of which indemnification or contribution could be sought under this Section 6 or Section 7
hereof (whether or not the indemnified parties are actual or potential parties thereto), unless
such settlement, compromise or consent (i) includes an unconditional release of each indemnified
party from all liability arising out of such litigation, investigation, proceeding or claim and
(ii) does not include a statement as to or an admission of fault, culpability or a failure to act
by or on behalf of any indemnified party.
(d) For purposes of this Section 6, all references to the Registration Statement, the Base
Prospectus, any preliminary prospectus supplement, Issuer Free Writing Prospectus, Final Term Sheet
or the Prospectus, or any amendment or supplement to any of the foregoing, shall be deemed to
include, without limitation, any electronically transmitted copies thereof, including, without
limitation, any copies filed with the Commission pursuant to XXXXX.
A-25
SECTION 7. Contribution. If the indemnification provided for in Section 6
hereof is for any reason unavailable to or insufficient to hold harmless an indemnified
party in respect of any losses, liabilities, claims, damages or expenses referred to
therein, then each indemnifying party shall contribute to the aggregate amount of such
losses, liabilities, claims, damages and expenses incurred by such indemnified party, as
incurred, (i) in such proportion as is appropriate to reflect the relative benefits received
by the Company on the one hand and the Underwriters on the other hand from the offering of
the Offered Securities pursuant to this Agreement or (ii) if the allocation provided by
clause (i) is not permitted by applicable law, in such proportion as is appropriate to
reflect not only the relative benefits referred to in clause (i) above but also the relative
fault of the Company on the one hand and of the Underwriters on the other hand in connection
with the statements or omissions which resulted in such losses, liabilities, claims, damages
or expenses, as well as any other relevant equitable considerations. The relative benefits
received by the Company on the one hand and the Underwriters on the other hand in connection
with the offering of the Offered Securities pursuant to this Agreement shall be deemed to be
in the same respective proportions as the total net proceeds from the offering of the
Offered Securities pursuant to this Agreement (before deducting expenses) received by the
Company and the total commission or underwriting discount received by each Underwriter, in
each case as set forth on the cover of the Prospectus Supplement, bear to the aggregate
initial public offering price of the Offered Securities sold to or through such Underwriter
as set forth on such cover. The relative fault of the Company on the one hand and the
Underwriters on the other hand shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company or by the
Underwriters and the parties’ relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The Company and the
Underwriters agree that it would not be just and equitable if contribution pursuant to this
Section 7 were determined by pro rata allocation (even if the Underwriters were treated as
one entity for such purpose) or by any other method of allocation which does not take
account of the equitable considerations referred to above in this Section 7. The aggregate
amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party
and referred to above in this Section 7 shall be deemed to include any legal or other
expenses reasonably incurred by such indemnified party in investigating, preparing or
defending against any litigation, or any investigation or proceeding by any governmental
agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue
or alleged untrue statement or omission or alleged omission. Notwithstanding the provisions
of this Section 7, no Underwriter shall be required to contribute any amount in excess of
the amount by which the total price at which the Offered Securities sold to or through such
Underwriter were offered to the public exceeds the amount of any damages which such
Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission. No person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the 0000 Xxx) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. For purposes of this
Section 7, each person, if any, who controls an Underwriter within the meaning of Section 15
of the 1933 Act or Section 20 of the 1934 Act shall have the
A-26
same rights to contribution as such Underwriter, and each director of the Company, each
officer of the Company who signed the Registration Statement, and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the
1934 Act shall have the same rights to contribution as the Company. The Underwriters’
respective obligations to contribute pursuant to this Section 7 are several in proportion to
the principal amount of Offered Securities sold to or through each Underwriter and not
joint.
SECTION 8. Representations, Warranties and Agreements to Survive Delivery. All
representations, warranties and agreements contained in this Agreement or in certificates of
officers of the Company submitted pursuant hereto or thereto shall remain operative and in
full force and effect, regardless of any investigation made by or on behalf of any
Underwriter or controlling person of an Underwriter, or by or on behalf of the Company, and
shall survive each delivery of and payment for any Offered Securities.
SECTION 9. Termination.
(a) The Representatives may terminate this Agreement immediately upon notice to the Company,
at any time at or prior to the Closing Time if (i) there has been, since the date of the Terms
Agreement or since the respective dates as of which information is given in the Registration
Statement, any material adverse change in the condition, financial or otherwise, or in the results
of operations, business affairs or business prospects of the Company and its subsidiaries
considered as one enterprise, whether or not arising in the ordinary course of business, or (ii)
there shall have occurred any material adverse change in the financial markets in the United States
or any outbreak or escalation of hostilities or other national or international calamity or crisis
the effect of which is such as to make it, in the judgment of the Representatives, impracticable or
inadvisable to market the Offered Securities or enforce contracts for the sale of the Offered
Securities, or (iii) trading in any securities of the Company has been suspended by the Commission
or a national securities exchange, or if trading generally on either the American Stock Exchange or
the New York Stock Exchange shall have been suspended, or minimum or maximum prices for trading
have been fixed, or maximum ranges for prices for securities have been required, by either of said
exchanges or by order of the Commission or any other governmental authority, or if a banking
moratorium shall have been declared by either Federal, New York or Texas authorities or if a
banking moratorium shall have been declared by the relevant authorities in the country or countries
of origin of any foreign currency or currencies in which the Offered Securities are denominated or
payable, or (iv) the rating assigned by any nationally recognized statistical rating organization
to any debt securities of the Company as of the date of the Terms Agreement shall have been lowered
since that date or if any such rating organization shall have publicly announced that it has under
surveillance or review, with possible negative implications, its rating of any debt securities of
the Company, or (v) there has been a material disruption in securities settlement, payment or
clearance services in the United States, or (vi) there shall have come to the attention of the
Representatives any facts that would cause them to reasonably believe that (x) the Disclosure
Package, at the Applicable Time, or (y) the Prospectus, at the time it was required to be delivered
to a purchaser of the Offered Securities, including in circumstances where such requirement may be
satisfied pursuant to Rule 172 of the 1933 Act Regulations, included an untrue statement of a
material fact or omitted to state a material fact necessary in order to make the statements
therein, in the light of
A-27
the circumstances existing at the time of such delivery, not misleading. As used in this
Section 9, the term “Prospectus” means the Prospectus in the form first provided to the applicable
Underwriter or Underwriters for use in confirming sales of the related Offered Securities.
(b) If this Agreement is terminated pursuant to this Section, such termination shall be
without liability of any party to any other party, except to the extent provided in Section 5.
Notwithstanding any such termination, (i) the covenants set forth in Section 3(b), (d), and (e)
with respect to any offering of Offered Securities shall remain in effect so long as any
Underwriter owns any such Offered Securities purchased from the Company pursuant to this Agreement
and during the period when the Prospectus is required to be delivered in connection with sales of
the Offered Securities and (ii) the covenants set forth in Section 3(c), (g), (h) and, if
applicable, (i), the provisions of Section 5, the indemnity agreement set forth in Section 6, the
contribution provisions set forth in Section 7 and the provisions of Sections 8, 11, 12 and 13
shall remain in effect.
SECTION 10. Default. If one or more of the Underwriters shall fail at the
Closing Time or a Date of Delivery to purchase the Immediate Delivery Offered Securities
which it or they are obligated to purchase under the applicable Terms Agreement (the
“Defaulted Securities”), then the Representatives shall have the right, within 24 hours
thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any
other underwriters, to purchase all, but not less than all, of the Defaulted Securities in
such amounts as may be agreed upon and upon the terms herein set forth. If, however, during
such 24 hours the Representatives shall not have completed such arrangements for the
purchase of all of the Defaulted Securities, then:
(a) if the amount of Defaulted Securities does not exceed 10% of the amount of
Immediate Delivery Offered Securities to be purchased on such date, each of the
non-defaulting Underwriters shall be obligated, severally and not jointly, to
purchase the full amount thereof in the proportions that their respective
underwriting obligations hereunder bear to the underwriting obligations of all
non-defaulting Underwriters, or
(b) if the amount of Defaulted Securities exceeds 10% of the number of Immediate
Delivery Offered Securities to be purchased on such date, the applicable Terms
Agreement or, with respect to any Date of Delivery which occurs after the Closing
Time, the obligation of the Underwriters to purchase and of the Company to sell the
Option Securities to be purchased and sold on such Date of Delivery shall terminate
without liability on the part of any non-defaulting Underwriter.
No action taken pursuant to this Section 10 shall relieve any defaulting Underwriter from
liability in respect of its default.
In the event of any such default which does not result in a termination of the applicable
Terms Agreement or, in the case of a Date of Delivery which is after the Closing Time, which does
not result in a termination of the obligation of the Underwriters to purchase and the Company to
sell the relevant Option Securities, as the case may be, either the Representatives or
A-28
the Company shall have the right to postpone the Closing Time or the relevant Date of
Delivery, as the case may be, for a period not exceeding seven days in order to effect any required
changes in the Registration Statement or the Prospectus or in any other documents or arrangements.
As used herein, the term “Underwriter” includes any person substituted for an Underwriter under
this Section 10.
SECTION 11. Notices. All notices and other communications hereunder shall be
in writing, either delivered by hand, by mail or by telex, telecopier or telegram, and any
such notice shall be effective when received at the address specified in this Section 11.
Notices to the Underwriters shall be directed as provided in the applicable Terms Agreement.
Notices to the Company shall be directed to Apache Corporation, 0000 Xxxx Xxx Xxxxxxxxx,
Xxxxx 000, Xxxxxxx, Xxxxx 00000-0000, Attention: Vice President and Treasurer, with a copy
to: Xxxxxxx Xxxxx LLP, 000 Xxxxxx, Xxxxx 0000, Xxxxxxx, Xxxxx 00000, Attention:
Xxxx Xxxxxxxxxxx, Esq. Any party to this Agreement may from time to time designate another
address to receive notice pursuant to this Agreement by notice duly given in accordance with
the terms of this Section 11.
SECTION 12. Parties. This Agreement shall inure to the benefit of and be
binding upon the Underwriters and the Company and their respective successors. Nothing
expressed or mentioned in this Agreement is intended or shall be construed to give any
person, firm or corporation, other than the parties hereto and their respective successors
and the controlling persons and officers and directors referred to in Sections 6 and 7 and
their heirs and legal representatives, any legal or equitable right, remedy or claim under
or in respect of this Agreement or any provision herein contained. This Agreement and all
conditions and provisions hereof are intended to be for the sole and exclusive benefit of
the parties hereto and their respective successors and said controlling persons and officers
and directors and their heirs and legal representatives, and for the benefit of no other
person, firm or corporation. No purchaser of Offered Securities from any Underwriter shall
be deemed to be a successor by reason merely of such purchase.
SECTION 13. Governing Law. This Agreement and all the rights and obligations
of the parties hereto shall be governed by and construed in accordance with the laws of the
State of New York applicable to agreements made and to be performed in such State.
SECTION 14. No Advisory or Fiduciary Responsibility. The Company acknowledges
and agrees that: (i) the purchase and sale of the Offered Securities pursuant to this
Agreement, including the determination of the public offering price of the Offered
Securities and any related discounts and commissions, is an arm’s-length commercial
transaction between the Company, on the one hand, and the several Underwriters, on the other
hand, and the Company is capable of evaluating and understanding and understands and accepts
the terms, risks and conditions of the transactions contemplated by this Agreement; (ii) in
connection with each transaction contemplated by this Agreement and the process leading to
such transaction each Underwriter is and has been acting solely as a principal and is not
the financial advisor, agent or fiduciary of the Company or its affiliates, stockholders,
creditors or employees or any other party; (iii) no Underwriter has assumed or will assume
an advisory, agency or fiduciary responsibility in favor of the Company with respect to any
of the transactions contemplated hereby or the process
A-29
leading thereto (irrespective of whether such Underwriter has advised or is currently
advising the Company on other matters) and no Underwriter has any obligation to the Company
with respect to the offering contemplated hereby except the obligations expressly set forth
in this Agreement; (iv) the several Underwriters and their respective affiliates may be
engaged in a broad range of transactions that involve interests that differ from those of
the Company and that the several Underwriters have no obligation to disclose any of such
interests by virtue of any advisory, agency or fiduciary relationship; and (v) the
Underwriters have not provided any legal, accounting, regulatory or tax advice with respect
to the offering contemplated hereby and the Company has consulted its own legal, accounting,
regulatory and tax advisors to the extent it deemed appropriate.
The Company hereby waives and releases, to the fullest extent permitted by law, any claims
that the Company may have against the several Underwriters with respect to any breach or alleged
breach of agency or fiduciary duty.
SECTION
15. Counterparts. Any Terms Agreement may be executed in one or more
counterparts and, if executed in more than one counterpart, the executed counterparts
thereof shall constitute a single instrument.
A-30
EXHIBIT A
FORM OF TERMS AGREEMENT
__, 20__
Apache Corporation
0000 Xxxx Xxx Xxxxxxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Attention: [Title]
0000 Xxxx Xxx Xxxxxxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Attention: [Title]
Ladies and Gentlemen:
The undersigned underwriters (the “Underwriters”) understand that Apache Corporation (the
“Company”) proposes to issue and sell $ aggregate principal amount of its debt securities
(the “Offered Securities”). Subject to the terms and conditions set forth herein or incorporated
by reference herein, the Underwriters offer to purchase, severally and not jointly, the principal
amount of Offered Securities set forth below opposite their
respective names at ___ % of the
principal amount thereof together with accrued interest thereon from
,
20 ___ to the
Closing Time:
Principal | ||||
Amount of | ||||
Underwriter | Debt Securities | |||
Total |
$ | |||
The Offered Securities shall have the following terms:
Principal amount:
Form and denomination:
Date of maturity:
Interest rate, rates or formula
(or method of calculation
of interest accrual):
Date from which interest accrues:
Interest payment dates, if any:
Initial price to public:
Closing Time:
Applicable Time:
Place of delivery and payment:
Company account for wire transfer of payment:
Redemption provisions, if any:
Lock-up pursuant to Section 3(i) of the
Form and denomination:
Date of maturity:
Interest rate, rates or formula
(or method of calculation
of interest accrual):
Date from which interest accrues:
Interest payment dates, if any:
Initial price to public:
Closing Time:
Applicable Time:
Place of delivery and payment:
Company account for wire transfer of payment:
Redemption provisions, if any:
Lock-up pursuant to Section 3(i) of the
A-31
Underwriting Agreement Basic Terms: [yes] [no]
Securities exchanges, if any, on which application will be made to list the Offered Securities:
Securities exchanges, if any, on which application will be made to list the Offered Securities:
Delayed Delivery Contracts: [authorized] [not authorized]
Delivery date:
Expiration date:
Compensation to Underwriters:
Minimum contract:
Maximum aggregate principal amount:
Final Term Sheet:
Other terms, if any:
Expiration date:
Compensation to Underwriters:
Minimum contract:
Maximum aggregate principal amount:
Final Term Sheet:
Other terms, if any:
All the provisions contained in “Apache Corporation-Debt Securities—Underwriting Agreement
Basic Terms” (the “Basic Terms”), filed as an exhibit to the Registration Statement relating to the
Offered Securities and attached hereto as Annex A, are herein incorporated by reference in their
entirety and shall be deemed to be a part of this Terms Agreement to the same extent as if such
provisions had been set forth in full herein. Terms defined in such document are used herein as
therein defined.
Any notice by the Company to the Underwriters pursuant to this Terms Agreement shall be
sufficient if given in accordance with Section 11 of the Basic Terms addressed to: [insert name and
address of the lead manager or managers or, if only one underwriter is a party hereto, of such
firm] which shall, for all purposes of this Agreement, be the “Representatives”.
Very truly yours, REPRESENTATIVE[S] |
||||
By: | ||||
[Acting for themselves and as Representative[s] of | ||||
the Underwriters] | ||||
Accepted: APACHE CORPORATION |
||||
By: | ||||
Title: | ||||
A-32
ANNEX A
[Apache Corporation—Debt Securities—
Underwriting Agreement Basic Terms]
Underwriting Agreement Basic Terms]
A-33
SCHEDULE 1
Final Term Sheet relating to the Offered Securities (attached as Exhibit A-1 to this Terms
Agreement).
X-00
XXXXXXX X-0
[Final Term Sheet]
A-35
EXHIBIT B
APACHE CORPORATION
[Title of Offered Securities]
DELAYED DELIVERY CONTRACT
[Title of Offered Securities]
DELAYED DELIVERY CONTRACT
Apache Corporation
0000 Xxxx Xxx Xxxxxxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Attention:
0000 Xxxx Xxx Xxxxxxxxx, Xxxxx 000
Xxxxxxx, Xxxxx 00000-0000
Attention:
Ladies and Gentlemen:
The undersigned hereby agrees to purchase from Apache Corporation (the “Company”), and the
Company agrees to sell to the undersigned on
,
20 ___ (the “Delivery Date”),
$ principal amount of the Company’s ___% Offered Securities due ___, 20___
(the “Offered Securities”), offered by the Company’s Prospectus dated ___, 20___, as
supplemented by its Prospectus Supplement dated ___, 20___, receipt of which is hereby
acknowledged, at a purchase price of ___% of the principal amount thereof, plus accrued interest
from , ___, to the Delivery Date, and on the further terms and conditions set forth in
this contract.
Payment for the securities which the undersigned has agreed to purchase on the Delivery Date
shall be made to the Company or its order by wire transfer in immediately available funds on the
Delivery Date, upon delivery to the undersigned of the Offered Securities to be purchased by the
undersigned in definitive or global form and in such denominations and registered in such names as
the undersigned may designate by written or telegraphic communication addressed to the Company not
less than three full business days prior to the Delivery Date.
The obligation of the undersigned to take delivery of and make payment for Offered Securities
on the Delivery Date shall be subject only to the conditions that (1) the purchase of Offered
Securities to be made by the undersigned shall not on the Delivery Date be prohibited under the
laws of the jurisdiction to which the undersigned is subject and (2) the Company, on or before
, ___, shall have sold to the Underwriters of the Offered Securities (the
“Underwriters”) such principal amount of the Offered Securities as is to be sold to them pursuant
to the Terms Agreement dated
, ___ between the Company and the Underwriters. The
obligation of the undersigned to take delivery of and make payment for Offered Securities shall not
be affected by the failure of any purchaser to take delivery of and make payment for Offered
Securities pursuant to other contracts similar to this contract. The undersigned represents and
warrants to the Underwriters that its investment in the Offered Securities is not, as of the date
hereof, prohibited under the laws of any jurisdiction to which the undersigned is subject and which
govern such investment.
Promptly after completion of the sale to the Underwriters, the Company will mail or deliver to
the undersigned at its address set forth below notice to such effect, accompanied by a copy of the
opinion of counsel for the Company delivered to the Underwriters in connection therewith.
A-36
By the execution hereof, the undersigned represents and warrants to the Company that all
necessary corporate action for the due execution and delivery of this contract and the payment for
and purchase of the Offered Securities has been taken by it and no further authorization or
approval of any governmental or other regulatory authority is required for such execution,
delivery, payment or purchase, and that, upon acceptance hereof by the Company and mailing or
delivery of a copy as provided below, this contract will constitute a valid and binding agreement
of the undersigned in accordance with its terms.
This contract will inure to the benefit of and be binding upon the parties hereto and their
respective successors, but will not be assignable by either party hereto without the written
consent of the other.
It is understood that the Company will not accept Delayed Delivery Contracts for an aggregate
principal amount of Offered Securities in excess of $ and that the acceptance of any
Delayed Delivery Contract is in the Company’s sole discretion and, without limiting the foregoing,
need not be on a first come first-served basis. If this contract is acceptable to the Company, it
is requested that the Company sign the form of acceptance on a copy hereof and mail or deliver a
signed copy hereof to the undersigned at its address set forth below. This will become a binding
contract between the Company and the undersigned when such copy is so mailed or delivered.
A-37
This Agreement shall be governed by the laws of the State New York applicable to agreements
made and performed in said State.
Yours very truly, | ||||||
(Name of Purchaser) | ||||||
By | ||||||
(Title) | ||||||
(Address) |
Accepted as of the date
first above written.
Apache Corporation
By: | ||||
PURCHASER — PLEASE COMPLETE AT TIME OF SIGNING
The name and telephone number of the representative of the Purchaser with whom details of
delivery on the Delivery Date shall be discussed is as follows: (Please print.)
Telephone No. | ||||
Name | (Including Area Code) | |||
X-00
XXXXX X
XXXX XX XXXXXXX SECURITIES LLC
X.X. XXXXXX SECURITIES INC.
BMO CAPITAL MARKETS CORP.
BNP PARIBAS SECURITIES CORP.
DEUTSCHE BANK SECURITIES INC.
GREENWICH CAPITAL MARKETS, INC.
RBC CAPITAL MARKETS CORPORATION
WACHOVIA CAPITAL MARKETS, LLC
X.X. XXXXXX SECURITIES INC.
BMO CAPITAL MARKETS CORP.
BNP PARIBAS SECURITIES CORP.
DEUTSCHE BANK SECURITIES INC.
GREENWICH CAPITAL MARKETS, INC.
RBC CAPITAL MARKETS CORPORATION
WACHOVIA CAPITAL MARKETS, LLC
B-1
SCHEDULE 1
1. | Final Term Sheet for the 2017 Notes (attached as Exhibit A-1 to this Terms Agreement) | |
2. | Final Term Sheet for the 2037 Notes (attached as Exhibit A-2 to this Terms Agreement) |
S-1
EXHIBIT A-1
PRICING TERM SHEET
Issuer: | Apache Corporation |
|
Expected Ratings: | A3(Xxxxx’x); A- (S&P); A (Fitch) None of these securities
ratings is a recommendation to buy, sell or hold these securities.
Each rating may be subject to revision or withdrawal at any time,
and should be evaluated independently of any other rating. |
|
Issue of Securities: | 5.625% Notes due 2017 |
|
Principal Amount: | $500,000,000 |
|
Coupon: | 5.625% |
|
Interest Payment Dates: | Semi-annually on January 15 and July 15, commencing on July 15, 2007 |
|
Maturity: | January 15, 2017 |
|
Treasury Benchmark: | 4.625% due November 15, 2016 |
|
U.S. Treasury Yield: | 4.808% |
|
Spread to Treasury: | 0.830% |
|
Re-offer Yield: | 5.638% |
|
Initial Price to Public: | Per Note: 99.904%; Total: $499,520,000 |
|
Optional Redemption: | The notes will be redeemable, at the option of Apache Corporation,
at any time, in whole or in part, at a redemption price equal to
the greater of (i) 100% of the principal amount and (ii) the sum of
the present values of the remaining scheduled payments of principal
and interest thereon discounted, on a semi-annual basis, at the
treasury yield plus 15 basis points, plus accrued interest to the
date of redemption. |
|
Make-Whole Premium: | T + 15 basis points |
|
Trade Date: | January 23, 2007 |
|
Settlement Date: | January 26, 2007 |
|
Denominations: | $2,000 x $1,000 |
|
CUSIP: | 000000XX0 |
|
Joint Book-Runners: | Banc of America Securities LLC |
|
X.X. Xxxxxx Securities Inc. |
||
Co-Managers: | BMO Capital Markets Corp. |
|
BNP Paribas Securities Corp. |
||
Deutsche Bank Securities Inc. |
||
Greenwich Capital Markets, Inc. |
||
RBC Capital Markets Corporation |
||
Wachovia Capital Markets, LLC |
The issuer has filed a registration statement (including a prospectus) with the
Securities and Exchange Commission for the offering to which this communication relates. Before
you invest, you should read the prospectus in that registration statement, the prospectus
supplement for this offering and other documents the issuer has filed with the Securities and
Exchange Commission for more complete information about the issuer and this offering. You may get
these documents for free by visiting XXXXX on the Securities and Exchange Commission’s website at
xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the
offering will arrange to send you the prospectus and the prospectus supplement if you request it by
calling Banc of America Securities LLC toll-free at 1-800-294-1322 or X.X. Xxxxxx Securities Inc.
collect at 000-000-0000.
EXHIBIT X-0-0
XXXXXXX X-0
PRICING TERM SHEET
Issuer: | Apache Corporation |
|
Expected Ratings: | A3(Xxxxx’x); A- (S&P); A (Fitch) None of these securities
ratings is a recommendation to buy, sell or hold these securities.
Each rating may be subject to revision or withdrawal at any time,
and should be evaluated independently of any other rating. |
|
Issue of Securities: | 6.000% Notes due 2037 |
|
Principal Amount: | $1,000,000,000 |
|
Coupon: | 6.000% |
|
Interest Payment Dates: | Semi-annually on January 15 and July 15, commencing on July 15, 2007 |
|
Maturity: | January 15, 2037 |
|
Treasury Benchmark: | 4.500% due February 15, 2036 |
|
U.S. Treasury Yield: | 4.901% |
|
Spread to Treasury: | 1.150% |
|
Re-offer Yield: | 6.051% |
|
Initial Price to Public: | Per Note: 99.301%; Total: $993,010,000 |
|
Optional Redemption: | The notes will be redeemable, at the option of Apache Corporation,
at any time, in whole or in part, at a redemption price equal to
the greater of (i) 100% of the principal amount and (ii) the sum of
the present values of the remaining scheduled payments of principal
and interest thereon discounted, on a semi-annual basis, at the
treasury yield plus 20 basis points, plus accrued interest to the
date of redemption. |
|
Make-Whole Premium: | T + 20 basis points |
|
Trade Date: | January 23, 2007 |
|
Settlement Date: | January 26, 2007 |
|
Denominations: | $2,000 x $1,000 |
|
CUSIP: | 000000XX0 |
|
Joint Book-Runners: | Banc of America Securities LLC |
|
X.X. Xxxxxx Securities Inc. |
||
Co-Managers: | BMO Capital Markets Corp. |
|
BNP Paribas Securities Corp. |
||
Deutsche Bank Securities Inc. |
||
Greenwich Capital Markets, Inc. |
||
RBC Capital Markets Corporation |
||
Wachovia Capital Markets, LLC |
The issuer has filed a registration statement (including a prospectus) with the
Securities and Exchange Commission for the offering to which this communication relates. Before
you invest, you should read the prospectus in that registration statement, the prospectus
supplement for this offering and other documents the issuer has filed with the Securities and
Exchange Commission for more complete information about the issuer and this offering. You may get
these documents for free by visiting XXXXX on the Securities and Exchange Commission’s website at
xxx.xxx.xxx. Alternatively, the issuer, any underwriter or any dealer participating in the
offering will arrange to send you the prospectus and the prospectus supplement if you request it by
calling Banc of America Securities LLC toll-free at 1-800-294-1322 or X.X. Xxxxxx Securities Inc.
collect at 000-000-0000.
EXHIBIT A-2-1